Life Sciences

The Canadian Science Centre for Human and Animal Health in Winnipeg is a global leader in infectious diseases laboratory science and the first facility in the world to have both human and animal containment level 4 (CL4) labs under one roof.

Halifax is home to ABK Biomedical, a medical device company dedicated to improving treatment options for patients with hypervascular tumours.

In Toronto, clinical trials are underway to validate the use of Myant’s Skiin, a textile-based monitoring solution, as a medical device to usher in a new paradigm in remote patient monitoring in health-care.

The Brain and Mental Health Initiative at the Cumming School of Medicine at the University of Calgary uses the clot-busting drug tPA to reduce stroke treatment time from 70 minutes to 36 minutes, among the fastest in the world for stroke treatments.

Montréal’s ExcellThera is a clinical stage cell and molecular medicine company, delivering molecules and bioengineering solutions to expand stem and immune cells for use in novel one-time therapies for patients with hematologic malignancies, as well as autoimmune and other diseases.

Among the full complement of cell biology research tools in STEMCELL Technologies’ Vancouver arsenal is CAR T-cell therapy, a rapidly emerging immunotherapy that seeks out and destroys cancerous cells to effectively target and treat types of leukemia.

AltaML, an Edmonton software company developing AI, and doctors associated with the Oliver Primary Care Network are working with pharmaceutical giant Boehringer Ingelheim Canada Ltd. to develop a frailty index that clinicians can use to predict chronic illnesses like diabetes, heart disease and mental health conditions.

Syantra Diagnostics in Calgary is developing a revolutionary, rapid and economical blood test to detect breast cancer that is accurate regardless of the test recipient's family history, age or tissue density.

In 2020, Dr. Michael Houghton, the Canada Excellence Research Chair in Virology, at the University of Alberta, was awarded the Nobel Prize in Physiology or Medicine for his discovery of the hepatitis C virus.

InteraXon, in Toronto, developed brainwave-sensing technology for applications like the Muse meditation headband.

By automating the delivery of oxygen to patients, Oxynov, based in Québec City, is preparing to create a revolution in health-care with its device developed at the Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ).

Immunovaccine, a clinical-stage immuno-oncology company in Halifax, is working to transform the way we engage human immunity to address some of the most complex and devastating diseases in today’s medical landscape, including COVID-19.

BioTraceIT™, developed in Charlottetown, focuses on novel technologies at the cutting edge of wearable health-care to quantify pain.